Sponsor or institution
Clinical trials and research at Zenas BioPharma (USA), LLC
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Zenas BioPharma (USA), LLC that are recruiting, at sites in 23 countries (most in Australia (2), Bulgaria (2), Croatia (2)). By phase: Phase 3 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 23Countries
All recruiting trials (2)
-
Orelabrutinib for non-active secondary progressive multiple sclerosis
This trial will try daily orelabrutinib versus placebo in adults with non-active secondary progressive multiple sclerosis to see if it slows disability progression.
-
Orelabrutinib treatment for primary progressive multiple sclerosis
This trial tests whether orelabrutinib, a brain-penetrant BTK inhibitor, can slow disability progression in adults with primary progressive MS.
Quick answers
How many clinical trials run by Zenas BioPharma (USA), LLC are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 23 countries. The most sites are in Australia (2 trials), Bulgaria (2 trials), Croatia (2 trials), Czechia (2 trials), Estonia (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.